gadodiamide

Also found in: Wikipedia.

gad·o·di·am·ide

(gad'ō-dī'ă-mid),

A nonionic structural analog of gadolinium DPTA; used as a paramagnetic contrast medium in magnetic resonance imaging.

References in periodicals archive ?

Also, Group II gadolinium-based agents, such as gadoteridol and gadobenate dimeglumine, should be used rather than Group I agents like gadodiamide and gadopentatate dimeglumine, which are associated with the greatest number of NSF cases.

MRI in abdominopelvic emergencies

Closely related diagnostic agents are gadobenate dimeglumine (MultiHance), gadodiamide (Omniscan), gadofosveset (Ablavar), gadopentetate dimeglumine (Magnevist), gadoteridol (Prohance), and gadoversetamide (OptiMARK).

Drugs approved in 2013

Patients At higher risk * Patients with CKD 4 and 5 (GFR < 30 ml/min) * Patients on dialysis * Patients with acute kidney insufficiency At lower risk * Patients with CKD 3 (GFR 30 - 59 ml/min) Not at risk of NSF * Patients with stable GFR > 60 ml/min) Highest risk of NSF Gadopentetate dimeglumine (Magnevist plus generic products) Gadodiamide (Omniscan) Gadoversetamide (Optimark) Recommendations for These agents are CONTRA-INDICATED high-risk group in: * patients with CKD 4 and 5 (GFR <30 ml/min), including those on dialysis * acute renal insufficiency * pregnant women * neonates These agents should be used with CAUTION in: * patients with CKD 3 (GFR 30 - 60 ml/min) * There should be at least 7 days between 2 injections.

Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)

She had the injection of Omniscan - also known as gadodiamide - at Glasgow's Gartnavel Hospital in September 2006.

I'm living with a death sentence; GRAN TAKES ON DRUGS GIANT EXCLUSIVE

Patient 5 had received gadodiamide (Omniscan, GE Healthcare, Waukesha, Wisconsin), whereas the other 5 patients each had received gadopentetate dimeglumine (Magnevist, Bayer HealthCare Pharmaceuticals, Montville, New Jersey) as intravenous contrast during magnetic resonance studies.

Nephrogenic systemic fibrosis: a pathologic study of autopsy cases

In the large majority of cases, the product used for MRI was gadodiamide (OMNISCAN(R)), in a smaller number of cases gadopentetate dimeglumine (MAGNEVIST(R)) or gadoversetamide (4,5,8) (OPTIMARK(R)) were used.

Contrast Media Used in MRI and Nephrogenic Systemic Fibrosis in Patients With Chronic Renal Failure: Guerbet Modifies the SPC of Dotarem(R) and Confirms Good Tolerance

Currently, there are four gadolinium-based contrast agents available commercially in the U5: gadodiamide (Omniscan; Amersham Health), gadopentetate dimeglumine (Magnevist; Schering), gadoversetamide (OptiMARK; Mallinckrodt Medical), and gadoteridol (Prohance; Bracco).

Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method

Contrast venography was performed with two 7 cc hand injections of gadodiamide (Omniscan, 0.

Section on Cardiology. (Abstracts of Scientific Posters)

Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.

MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco's MultiHance[R] (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist[TM] (gadobutrol injection)

As of February 1, 2008, there have been 190 biopsy-proven cases of NSF published in the peer-reviewed literature with the following associations: 157 gadodiamide (ONISCAN), 8 gadopentetate (MAGNEVIST), 3 gadoversetamide (Optimark), and 18 unspecified GBCA, and 4 confounded cases with >1 GBCA.

MR contrast agents: applications in hepatobiliary imaging

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.